Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,999 | 30,296 | 14,115 | 10,251 | 8,322 |
| Marketable Securities | 1,846 | 13,543 | N/A | 17,000 | 14,700 |
| Receivables | 105 | 318 | 671 | 1,140 | 326 |
| TOTAL | $22,877 | $44,567 | $15,264 | $29,004 | $24,472 |
| Non-Current Assets | |||||
| PPE Net | 277 | 344 | 354 | 402 | 391 |
| Investments And Advances | 11,361 | 12,331 | 13,451 | 0 | 0 |
| Intangibles | 21,293 | 23,082 | 9,751 | 10,087 | 10,805 |
| Other Non-Current Assets | 259 | 306 | 167 | 282 | 282 |
| TOTAL | $33,190 | $36,062 | $23,723 | $10,771 | $11,478 |
| Total Assets | $56,067 | $80,629 | $38,987 | $39,775 | $35,950 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 12,115 | 12,109 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,092 | 3,891 | 1,367 | 1,807 | 2,010 |
| Accrued Expenses | 178 | 299 | 400 | 574 | 675 |
| Other current liabilities | 371 | 2,775 | 225 | 367 | 3,541 |
| TOTAL | $6,437 | $19,350 | $14,710 | $3,355 | $6,860 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 796 | 270 | 608 | 606 | 634 |
| Other Non-Current Liabilities | 25 | 47 | 0 | 0 | 5,350 |
| TOTAL | $2,530 | $94 | $5,171 | $5,386 | $10,938 |
| Total Liabilities | $8,967 | $19,444 | $19,881 | $8,740 | $17,798 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,650 | 2,140 | 917 | 913 | 795 |
| Common Shares | 105 | 103 | 44 | 44 | 36 |
| Retained earnings | -194,838 | -177,224 | -152,813 | -139,847 | -128,620 |
| Other shareholders' equity | 601 | 729 | 6 | 108 | -49 |
| TOTAL | $47,101 | $61,185 | $19,106 | $31,035 | $18,152 |
| Total Liabilities And Equity | $56,067 | $80,629 | $38,987 | $39,775 | $35,950 |